We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+18.51%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$207M
AUM Growth
+$19.7M
Cap. Flow
-$2.22M
Cap. Flow %
-1.07%
Top 10 Hldgs %
43.03%
Holding
83
New
21
Increased
16
Reduced
17
Closed
24

Top Buys

Rank Stock Value
1
XLRN
Acceleron Pharma
XLRN
+$6.62M
2
SHPG
Shire pic
SHPG
+$4.24M
3
SNY icon
Sanofi
SNY
+$4.12M
4
CELG
Celgene Corp
CELG
+$3.69M
5
VOLC
VOLCANO CORPORATION COM STK
VOLC
+$2.4M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$7.25M
2
IONS icon
Ionis Pharmaceuticals
IONS
+$3.3M
3
ABBV icon
AbbVie
ABBV
+$3.15M
4
ZBH icon
Zimmer Biomet
ZBH
+$2.71M
5
DXCM icon
DexCom
DXCM
+$2.6M

Sector Composition

Rank Sector Weight
1 Healthcare 70.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACHN
51
DELISTED
Achillion Pharmaceuticals
ACHN
$919K 0.44%
+75,000
New +$916K
BCRX icon
52
BioCryst Pharmaceuticals
BCRX
$2.64B
$912K 0.44%
+75,000
New +$828K
DERM
53
DELISTED
Dermira, Inc.
DERM
$906K 0.44%
+50,000
New +$836K
NKTR icon
54
CALL
Nektar Therapeutics
NKTR
$2.55B
$775K 0.37%
+3,333
New +$712K
LITS
55
CALL
Lite Strategy Inc
LITS
$30.7M
$427K 0.21%
+5,000
New +$658K
KERX
56
CALL
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$425K 0.21%
+30,000
New +$465K
ASMB icon
57
Assembly Biosciences
ASMB
$540M
$393K 0.19%
4,167
– –
ELGX
58
DELISTED
Endologix Inc
ELGX
$382K 0.18%
2,500
-15,750
-86% -$1.97M
QDEL icon
59
CALL
QuidelOrtho
QDEL
$959M
$289K 0.14%
+10,000
New +$271K
AGIO icon
60
PUT
Agios Pharmaceuticals
AGIO
$1.95B
– –
-10,000
Closed -$614K
AMGN icon
61
CALL
Amgen
AMGN
$224B
– –
-17,500
Closed -$2.46M
ARWR icon
62
Arrowhead Research
ARWR
$12.6B
– –
-90,000
Closed -$1.33M
BMRN icon
63
BioMarin Pharmaceuticals
BMRN
$13.5B
– –
-25,000
Closed -$1.8M
CLDX icon
64
CALL
Celldex Therapeutics
CLDX
$3.48B
– –
-5,000
Closed -$972K
DXCM icon
65
DexCom
DXCM
$33.8B
– –
-260,000
Closed -$2.6M
IONS icon
66
Ionis Pharmaceuticals
IONS
$9.21B
– –
-85,000
Closed -$3.3M
MRK icon
67
PUT
Merck
MRK
$322B
– –
-41,920
Closed -$2.37M
PFE icon
68
CALL
Pfizer
PFE
$152B
– –
-105,400
Closed -$2.96M
REGN icon
69
PUT
Regeneron Pharmaceuticals
REGN
$82.1B
– –
-10,000
Closed -$3.6M
SNY icon
70
CALL
Sanofi
SNY
$104B
– –
-50,000
Closed -$2.82M
UTHR icon
71
CALL
United Therapeutics
UTHR
$22.1B
– –
-25,000
Closed -$3.22M
VNDA icon
72
Vanda Pharmaceuticals
VNDA
$298M
– –
-50,000
Closed -$519K
XLB icon
73
PUT
State Street Materials Select Sector SPDR ETF
XLB
$8.72B
– –
-200,000
Closed -$6.39M
GWPH
74
CALL
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-10,000
Closed -$809K
WMGI
75
CALL
DELISTED
Wright Medical Group Inc
WMGI
– –
-25,000
Closed -$758K
1 2
3
4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q4 2014 Portfolio in Review

As of Q4 2014, Iguana Healthcare Management held 83 positions worth $207M, up 11% from $187M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Iguana Healthcare Management's Q4 2014 filing shows 21 new, 16 increased, 17 reduced and 24 closed positions. Its largest new stake was Shire pic: 20,000 shares worth $4.25M. The largest sale was Amgen, an estimated $7.25M.

By sector, the portfolio is most concentrated in Healthcare at 71% of assets, down from 71% a quarter earlier.

  • Iguana Healthcare Management's largest Q4 2014 buy was Shire pic: 20,000 shares worth $4.25M.
  • Iguana Healthcare Management added most to Acceleron Pharma in Q4 2014, an estimated $6.62M increase.
  • Iguana Healthcare Management's biggest Q4 2014 reduction was Amgen, cutting an estimated $7.25M.
  • Iguana Healthcare Management fully exited Ionis Pharmaceuticals in Q4 2014, selling an estimated $3.3M.
  • Iguana Healthcare Management's ten largest holdings make up 43% of its $207M portfolio in Q4 2014.
  • Iguana Healthcare Management opened 21 new positions and closed 24 in Q4 2014.
  • Iguana Healthcare Management's portfolio value rose 11% quarter-over-quarter to $207M.

Based on Iguana Healthcare Management's 13F filing for Q4 2014, filed 18 Feb 2015.